108 related articles for article (PubMed ID: 14998484)
1. c-maf in multiple myeloma: an oncogene enhancing tumor-stroma interactions.
Kienast J; Berdel WE
Cancer Cell; 2004 Feb; 5(2):109-10. PubMed ID: 14998484
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma.
Hurt EM; Wiestner A; Rosenwald A; Shaffer AL; Campo E; Grogan T; Bergsagel PL; Kuehl WM; Staudt LM
Cancer Cell; 2004 Feb; 5(2):191-9. PubMed ID: 14998494
[TBL] [Abstract][Full Text] [Related]
3. TACI expression is associated with a mature bone marrow plasma cell signature and C-MAF overexpression in human myeloma cell lines.
Moreaux J; Hose D; Jourdan M; Reme T; Hundemer M; Moos M; Robert N; Moine P; De Vos J; Goldschmidt H; Klein B
Haematologica; 2007 Jun; 92(6):803-11. PubMed ID: 17550853
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of c-Maf contributes to T-cell lymphoma in both mice and human.
Morito N; Yoh K; Fujioka Y; Nakano T; Shimohata H; Hashimoto Y; Yamada A; Maeda A; Matsuno F; Hata H; Suzuki A; Imagawa S; Mitsuya H; Esumi H; Koyama A; Yamamoto M; Mori N; Takahashi S
Cancer Res; 2006 Jan; 66(2):812-9. PubMed ID: 16424013
[TBL] [Abstract][Full Text] [Related]
5. C-MAF oncogene dysregulation in multiple myeloma: frequency and biological relevance.
Rasmussen T; Knudsen LM; Dahl IM; Johnsen HE
Leuk Lymphoma; 2003 Oct; 44(10):1761-6. PubMed ID: 14692531
[TBL] [Abstract][Full Text] [Related]
6. The ubiquitin-conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosis.
Xu Y; Zhang Z; Li J; Tong J; Cao B; Taylor P; Tang X; Wu D; Moran MF; Zeng Y; Mao X
J Hematol Oncol; 2017 Jul; 10(1):132. PubMed ID: 28673317
[TBL] [Abstract][Full Text] [Related]
7. A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitin.
Mao X; Stewart AK; Hurren R; Datti A; Zhu X; Zhu Y; Shi C; Lee K; Tiedemann R; Eberhard Y; Trudel S; Liang S; Corey SJ; Gillis LC; Barber DL; Wrana JL; Ezzat S; Schimmer AD
Blood; 2007 Dec; 110(12):4047-54. PubMed ID: 17875808
[TBL] [Abstract][Full Text] [Related]
8. Identification of small compounds that inhibit multiple myeloma proliferation by targeting c-Maf transcriptional activity.
Asano K; Kikuchi K; Takehara M; Ogasawara M; Yoshioka Y; Ohnishi K; Iwata A; Shimizu S; Tanaka M
Biochem Biophys Res Commun; 2023 Dec; 684():149135. PubMed ID: 37879249
[TBL] [Abstract][Full Text] [Related]
9. The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages.
Cao S; Liu J; Song L; Ma X
J Immunol; 2005 Mar; 174(6):3484-92. PubMed ID: 15749884
[TBL] [Abstract][Full Text] [Related]
10. Functional regulation of D-type cyclins by insulin-like growth factor-I and serum in multiple myeloma cells.
Glassford J; Rabin N; Lam EW; Yong KL
Br J Haematol; 2007 Oct; 139(2):243-54. PubMed ID: 17897300
[TBL] [Abstract][Full Text] [Related]
11. MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells.
Oba Y; Lee JW; Ehrlich LA; Chung HY; Jelinek DF; Callander NS; Horuk R; Choi SJ; Roodman GD
Exp Hematol; 2005 Mar; 33(3):272-8. PubMed ID: 15730850
[TBL] [Abstract][Full Text] [Related]
12. NF-kappa B p65 antagonizes IL-4 induction by c-maf in minimal change nephrotic syndrome.
Valanciuté A; le Gouvello S; Solhonne B; Pawlak A; Grimbert P; Lyonnet L; Hue S; Lang P; Remy P; Salomon R; Bensman A; Guellaën G; Sahali D
J Immunol; 2004 Jan; 172(1):688-98. PubMed ID: 14688382
[TBL] [Abstract][Full Text] [Related]
13. AhR- and c-maf-dependent induction of beta7-integrin expression in human macrophages in response to environmental polycyclic aromatic hydrocarbons.
Monteiro P; Gilot D; Le Ferrec E; Lecureur V; N'diaye M; Le Vee M; Podechard N; Pouponnot C; Fardel O
Biochem Biophys Res Commun; 2007 Jun; 358(2):442-8. PubMed ID: 17490615
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitination of the transcription factor c-MAF is mediated by multiple lysine residues.
Chen G; Xu X; Tong J; Han K; Zhang Z; Tang J; Li S; Yang C; Li J; Cao B; Zhou H; Wu D; Moran MF; Mao X
Int J Biochem Cell Biol; 2014 Dec; 57():157-66. PubMed ID: 25448412
[TBL] [Abstract][Full Text] [Related]
15. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
[TBL] [Abstract][Full Text] [Related]
16. Expression of the cell-cycle-related proteins E2F-1, p53, mdm-2, p21waf-1, and Ki-67 in multiple myeloma: correlation with cyclin-D1 immunoreactivity.
Lai R; Medeiros LJ; Wilson CS; Sun NC; Koo C; McCourty A; Brynes RK
Mod Pathol; 1998 Jul; 11(7):642-7. PubMed ID: 9688185
[TBL] [Abstract][Full Text] [Related]
17. Protein Expression for Novel Prognostic Markers (Cyclins D1, D2, D3, B1, B2, ITGβ7, FGFR3, PAX5) Correlate With Previously Reported Gene Expression Profile Patterns in Plasma Cell Myeloma.
Mansoor A; Akhter A; Pournazari P; Mahe E; Shariff S; Farooq F; Elyamany G; Shahbani-Rad MT; Rashid-Kolvear F
Appl Immunohistochem Mol Morphol; 2015; 23(5):327-33. PubMed ID: 25265432
[TBL] [Abstract][Full Text] [Related]
18. Identification of primary MAFB target genes in multiple myeloma.
van Stralen E; van de Wetering M; Agnelli L; Neri A; Clevers HC; Bast BJ
Exp Hematol; 2009 Jan; 37(1):78-86. PubMed ID: 19013005
[TBL] [Abstract][Full Text] [Related]
19. Selective usage of D-Type cyclins by Ewing's tumors and rhabdomyosarcomas.
Zhang J; Hu S; Schofield DE; Sorensen PH; Triche TJ
Cancer Res; 2004 Sep; 64(17):6026-34. PubMed ID: 15342383
[TBL] [Abstract][Full Text] [Related]
20. Regulation and differential expression of the c-maf gene in differentiating cultured cells.
Serria MS; Ikeda H; Omoteyama K; Hirokawa J; Nishi S; Sakai M
Biochem Biophys Res Commun; 2003 Oct; 310(2):318-26. PubMed ID: 14521912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
